Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T18:55:35.165Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:55:35.165Z.

Quote observation: 2026-10-06T18:55:04.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 520,976,399
Total debt · period ending 2026-06-30: 35,746,000
Cash · period ending 2026-06-30: 63,050,000
TTM free cash flow · period ending 2026-06-30: -76,562,000

FMP input reference: 3eea2ebb4dfb8ae449a8fc068c41cc3e6d53bf63d9a404ece64f578f5b067b33

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

ALT EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

N/A

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

ALT Competitors' EV/FCF Ratio

ALT

Altimmune, Inc.

Current

Market Cap

$520.98M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACRS

Aclaris Therapeutics, Inc.

vs ALT

Market Cap

$522.51M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BLSM

BlossomHill Therapeutics, Inc.

vs ALT

Market Cap

$520.84M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMMX

Immix Biopharma, Inc.

vs ALT

Market Cap

$523.79M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CBIO

Crescent Biopharma, Inc.

vs ALT

Market Cap

$511.66M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MASS

908 Devices Inc.

vs ALT

Market Cap

$510.29M

EV/FCF Ratio

936.86x

TTM Avg

716.21x

3Y Avg

716.21x

5Y Avg

716.21x

ALLO

Allogene Therapeutics, Inc.

vs ALT

Market Cap

$509.90M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NVCT

Nuvectis Pharma, Inc.

vs ALT

Market Cap

$533.38M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCTH

Delcath Systems, Inc.

vs ALT

Market Cap

$535.09M

EV/FCF Ratio

27.99x

TTM Avg

31.80x

3Y Avg

42.09x

5Y Avg

42.09x

PHAT

Phathom Pharmaceuticals, Inc.

vs ALT

Market Cap

$538.76M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Altimmune, Inc. (ALT)	$520.98M	N/A	N/A	N/A	N/A
Aclaris Therapeutics, Inc. (ACRS)vs ›	$522.51M	N/A	N/A	N/A	N/A
BlossomHill Therapeutics, Inc. (BLSM)vs ›	$520.84M	N/A	N/A	N/A	N/A
Immix Biopharma, Inc. (IMMX)vs ›	$523.79M	N/A	N/A	N/A	N/A
Crescent Biopharma, Inc. (CBIO)vs ›	$511.66M	N/A	N/A	N/A	N/A
908 Devices Inc. (MASS)vs ›	$510.29M	936.86x	716.21x	716.21x	716.21x
Allogene Therapeutics, Inc. (ALLO)vs ›	$509.90M	N/A	N/A	N/A	N/A
Nuvectis Pharma, Inc. (NVCT)vs ›	$533.38M	N/A	N/A	N/A	N/A
Delcath Systems, Inc. (DCTH)vs ›	$535.09M	27.99x	31.80x	42.09x	42.09x
Phathom Pharmaceuticals, Inc. (PHAT)vs ›	$538.76M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

ALT EV/FCF Ratio History

DATE	EV/FCF RATIO
2018-03-29	0.02x
2018-03-28	0.01x
2018-03-27	0.05x
2018-03-26	0.11x
2018-03-23	0.11x
2018-03-22	0.11x
2018-03-21	0.12x
2018-03-20	0.12x
2018-03-19	0.13x
2018-03-16	0.13x
2018-03-15	0.15x
2018-03-14	0.15x
2018-03-13	0.17x
2018-03-12	0.16x
2018-03-09	0.16x
2018-03-08	0.14x
2018-03-07	0.12x
2018-03-06	0.10x
2018-03-05	0.12x
2018-03-02	0.13x
2018-03-01	0.12x
2018-02-28	0.12x
2018-02-27	0.11x
2018-02-26	0.12x
2018-02-23	0.11x
2018-02-22	0.10x
2018-02-21	0.12x
2018-02-20	0.10x
2018-02-16	0.09x
2018-02-15	0.09x
2018-02-14	0.10x
2018-02-13	0.08x
2018-02-12	0.10x
2018-02-09	0.12x
2018-02-08	0.11x
2018-02-07	0.12x
2018-02-06	0.12x
2018-02-05	0.12x
2018-02-02	0.12x
2018-02-01	0.13x
2018-01-31	0.17x
2018-01-30	0.18x
2018-01-29	0.19x
2018-01-26	0.18x
2018-01-25	0.18x
2018-01-24	0.20x
2018-01-23	0.18x
2018-01-22	0.18x
2018-01-19	0.18x
2018-01-18	0.18x
2018-01-17	0.19x
2018-01-16	0.19x
2018-01-12	0.21x
2018-01-11	0.21x
2018-01-10	0.21x
2018-01-09	0.21x
2018-01-08	0.21x
2018-01-05	0.22x
2018-01-04	0.21x
2018-01-03	0.22x
2018-01-02	0.22x
2017-12-29	0.21x
2017-12-28	0.20x
2017-12-27	0.16x
2017-12-26	0.16x
2017-12-22	0.12x
2017-12-21	0.11x
2017-12-20	0.12x
2017-12-19	0.13x
2017-12-18	0.12x
2017-12-15	0.13x
2017-12-14	0.13x
2017-12-13	0.15x
2017-12-12	0.13x
2017-12-11	0.14x
2017-12-08	0.16x
2017-12-07	0.17x
2017-12-06	0.17x
2017-12-05	0.18x
2017-12-04	0.17x
2017-12-01	0.17x
2017-11-30	0.17x
2017-11-29	0.20x
2017-11-28	0.20x
2017-11-27	0.21x
2017-11-24	0.23x
2017-11-22	0.24x
2017-11-21	0.23x
2017-11-20	0.23x
2017-11-17	0.25x
2017-11-16	0.25x
2017-11-15	0.23x
2017-11-14	0.25x
2017-11-13	0.26x
2017-11-10	0.29x
2017-11-09	0.11x
2017-11-08	0.11x
2017-11-07	0.11x
2017-11-06	0.11x
2017-11-03	0.10x
2017-11-02	0.11x
2017-11-01	0.11x
2017-10-31	0.12x
2017-10-30	0.12x
2017-10-27	0.13x
2017-10-26	0.13x
2017-10-25	0.13x
2017-10-24	0.14x
2017-10-23	0.14x
2017-10-20	0.14x
2017-10-19	0.14x
2017-10-18	0.12x
2017-10-17	0.13x
2017-10-16	0.12x
2017-10-13	0.12x
2017-10-12	0.13x
2017-10-11	0.13x
2017-10-10	0.13x
2017-10-09	0.13x
2017-10-06	0.11x
2017-10-05	0.11x
2017-10-04	0.11x
2017-10-03	0.11x
2017-10-02	0.11x
2017-09-29	0.11x
2017-09-28	0.11x
2017-09-27	0.11x
2017-09-26	0.11x
2017-09-25	0.11x
2017-09-22	0.12x
2017-09-21	0.13x
2017-09-20	0.13x
2017-09-19	0.12x
2017-09-18	0.11x
2017-09-15	0.12x
2017-09-14	0.13x
2017-09-13	0.13x
2017-09-12	0.13x
2017-09-11	0.12x
2017-09-08	0.12x
2017-09-07	0.12x
2017-09-06	0.12x
2017-09-05	0.12x
2017-09-01	0.13x
2017-08-31	0.13x
2017-08-30	0.12x
2017-08-29	0.14x
2017-08-28	0.12x
2017-08-25	0.10x
2017-08-24	0.10x
2017-08-23	0.11x
2017-08-22	0.10x
2017-08-21	0.09x
2017-08-18	0.09x
2017-08-17	0.09x
2017-08-16	0.10x
2017-08-15	0.10x
2017-08-14	0.11x
2017-08-11	0.02x
2017-08-10	0.02x
2017-08-09	0.02x
2017-08-08	0.03x
2017-08-07	0.03x
2017-08-04	0.02x
2017-08-03	0.03x
2017-08-02	0.02x
2017-08-01	0.02x
2017-07-31	0.03x
2017-07-28	0.04x
2017-07-27	0.04x
2017-07-26	0.04x
2017-07-25	0.04x
2017-07-24	0.03x
2017-07-21	0.03x
2017-07-20	0.03x
2017-07-19	0.03x
2017-07-18	0.03x
2017-07-17	0.03x
2017-07-14	0.04x
2017-07-13	0.04x
2017-07-12	0.03x
2017-07-11	0.04x
2017-07-10	0.04x
2017-07-07	0.05x
2017-07-06	0.05x
2017-07-05	0.05x
2017-07-03	0.06x
2017-06-30	0.05x
2017-06-29	0.05x
2017-06-28	0.06x
2017-06-27	0.06x
2017-06-26	0.07x
2017-06-23	0.07x
2017-06-22	0.08x
2017-06-21	0.08x
2017-06-20	0.07x
2017-06-19	0.08x
2017-06-16	0.07x
2017-06-15	0.08x
2017-06-14	0.08x
2017-06-13	0.09x
2017-06-12	0.08x
2017-06-09	0.08x
2017-06-08	0.08x
2017-06-07	0.08x
2017-06-06	0.09x
2017-06-05	0.09x
2017-06-02	0.09x
2017-06-01	0.09x
2017-05-31	0.09x
2017-05-30	0.09x
2017-05-26	0.10x

EV/FCF Ratio: N/A

ALT EV/FCF Ratio Chart

ALT EV/FCF Ratio Metrics

ALT Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

ALT EV/FCF Ratio History

Related Metrics